Tag Archives: AbbVie Inc (ABBV)

Teva Pharmaceutical Industries TEVA

Teva Pharmaceutical Industries Ltd (ADR) (TEVA), AbbVie Inc (ABBV), Cheniere Energy, Inc. (LNG): Top 3 Holdings of Point State Capital LP

Teva Pharmaceutical Industries Ltd (ADR) (TEVA), AbbVie Inc (ABBV), Cheniere Energy, Inc. (LNG): Top 3 Holdings of Point State Capital LP

Point State Capital LP is a global a hedge fund manager that focuses on macro investments. The company was founded in November 2010 by its current CEO Sean Cullinan and some of his former colleagues. According to the SEC 13F filings of Point State Capital LP for the quarter ended September 30, 2014, its primary

AbbVie Inc (ABBV)

AbbVie Inc (ABBV), Celgene Corporation (CELG), Sanofi SA (ADR) (SNY) Approved by EU Endorsements

AbbVie Inc (NYSE:ABBV), Celgene Corporation (NASDAQ:CELG), and Sanofi SA (ADR) (NYSE:SNY) got the approval of the medical advisory committee of the European Union last Friday, allowing the drug makers to sell key brands, at least two of which are estimated to be market blockbusters. AbbVie Inc (NYSE:ABBV) was given a positive review on its Viekirax

Actavis plc (ACT)

Actavis PLC (ACT), AbbVie Inc (ABBV), Allergan, Inc. (AGN): Top 3 Holdings of Oz Management

Oz Management is a privately-owned hedge fund manager that also offers alternative asset management services to clients across the globe. The firm provides its management services to different entities, including corporations, funds, collateralized loan obligations, and more. Oz Management recently submitted its SEC 13F filings for the period ended September 30, 2014. The filings showed

AbbVie Inc (ABBV)

AbbVie Inc (ABBV) Reevaluates Acquisition of Shire PLC (ADR) (SHPG) Over New U.S. Tax Rules

AbbVie Inc (NYSE:ABBV) is said to be considering withdrawing its bid for the acquisition of its UK based competitor Shire PLC (ADR) (NASDAQ:SHPG), citing new tax rules by the U.S. government. The U.S. drug firm had agreed to acquire the UK rival in a $52 billion deal. The U.S. Company said that it will have

AbbVie Inc (ABBV)

AbbVie Inc (ABBV), Gilead Sciences, Inc. (GILD), Ecolab Inc. (ECL): Top 3 Stock Holdings of Swarthmore Group Inc CIK

Swarthmore Group Inc CIK has 13F portfolio worths $1.07 billion, as per its recent SEC 13F filing, and its top 10 holdings account for 46.87% of its net portfolio. Ms. Paula Mandle is the CEO of the Swarthmore Group, Inc and it was founded in 1991 James E. Nevels. AbbVie Inc (NYSE:ABBV), Gilead Sciences, Inc. (NASDAQ:GILD),

Google (GOOG)

Google Inc (GOOGL), AbbVie Inc (ABBV) Join Hands to Combat Ageing

Through its representative in the field of medical science, Calico, Google Inc (NASDAQ:GOOGL) has forged a partnership with the renowned American drug manufacturer AbbVie Inc (NYSE:ABBV), the intention being to combat illnesses that arise due to ageing. This joint venture is poised at $500 million with each of the two companies investing $250 million and

AbbVie Inc (ABBV)

Google-Funded Calico Resources Corp (CKB) and AbbVie Inc (ABBV) to Jointly Launch a $1.5 Billion Aging Research Center

Calico Resources Corp (CVE:CKB), a company funded by Google Inc(NASDAQ:GOOG), and biopharmaceutical firm, AbbVie Inc (NYSE:ABBV), have announced a partnership to set up a research and development center. Cnet has said in an article that the two companies will be contributing the amount equally with the upfront being $250 million each. The balance will then

AbbVie Inc (ABBV), Perrigo Company plc Ordinary Shares (PRGO), Actavis plc (ACT) and Mallinckrodt PLC (MNK): Cramer’s Favorite Drug Manufacturer Picks in August

AbbVie Inc (NYSE:ABBV), Perrigo Company plc Ordinary Shares (NYSE:PRGO), Actavis plc (NYSE:ACT), Mallinckrodt PLC (NYSE:MNK) are the Cramer’s favorite Drug Manufacturers which have been recommended on Mad Money TV show on August. For AbbVie Inc (NYSE:ABBV), Cramer said, “I’m a buyer. It’s a good stock to own.” AbbVie Inc (NYSE:ABBV) has been working hard to

AbbVie Inc (ABBV)

AbbVie Inc (ABBV), Medtronic, Inc. (MDT) and Union Pacific Corporation (UNP): Analysts Are Bullish About These Stocks

According to the recent study by Bespoke Investment Group, analysts are bullish about 13 stocks on which higher than 70% of the analyts have buy ratings in the Standard & Poor’s 500. Three of these stocks are AbbVie Inc (NYSE:ABBV), Medtronic, Inc. (NYSE:MDT) and Union Pacific Corporation (NYSE:UNP). AbbVie Inc (NYSE:ABBV) is one of the